Navigation Links
Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product
Date:6/30/2008

- Company Expects to Submit Complete Response by End of Week -

LAVAL, QC, June 30 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that the Company has received a response from the U.S. Food and Drug Administration (FDA) regarding its most recent appeal of the decision in the Agency's Approvable Letter for its once-daily tramadol formulation through the Formal Dispute Resolution process.

Procedurally, Dr. Douglas Throckmorton, M.D., the FDA's Deputy Director, Center for Drug Evaluation and Research, agreed with Dr. Jenkins, M.D., Director for the Office of New Drugs, Center for Drug Evaluation and Research and denied the appeal. However, he suggested a regulatory path forward. Dr. Throckmorton has suggested that the Company submit the analysis put forward by Dr. Jenkins in his letter of earlier this year. In the response, the FDA has concluded that a positive finding using this analysis could provide the needed assurance to support the efficacy of Labopharm's once-daily tramadol. Following resolution of any issues with labeling, such a finding would lead to the approval of the product.

The Company expects to submit the complete response before the end of the week and the FDA has agreed to conduct its review of the response in a timely basis.

"We are encouraged by the Agency's request to formally submit the data analysis that Dr. Jenkins suggested we undertake and believe that this is a positive step towards regulatory approval in the U.S.," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. "The request follows a meeting with the FDA, as well as constructive discussions over the past two months. We continue to believe that the comprehensive data generated by our global clinical trial program demonstrates the efficacy and safety of our once-daily tramadol formulation and that we have met the statutory standards for approval of our formulation."

Labopharm has co
'/>"/>

SOURCE Labopharm Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Labopharm Reports Results for First Quarter Fiscal 2008
2. Labopharm announces details for first quarter results conference call and annual meeting
3. Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer
4. Labopharm Appeals FDAs Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy
5. Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
6. Labopharms Once-Daily Tramadol Approved in South Korea and Australia
7. Labopharm to host conference call Thursday, February 21, 2008 at 8:30 a.m. (ET)
8. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
9. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
10. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
11. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... Love Digits LLC has successfully launched ... The App brings ancient astrology to the modern dating ... compatibility using a five-star rating system. By entering their ... test their compatibility for love and marriage across seven ... five-star rating system generates a weighted average of the ...
(Date:7/14/2014)... Spine Team Texas continues to ... to treatment and recovery. Currently all physical therapists at ... training for certification in The McKenzie Method. Two therapists, ... extensive program. , “We require certification of our therapists ... better outcomes for spine pain patients,” said Mark Hood, ...
(Date:7/14/2014)... WA (PRWEB) July 14, 2014 ... solutions, today announced its new IBM i (AS/400, ... Software Vendors (ISVs). As security threats evolve and ... software providers struggle to modernize their applications and ... program now makes it easy for ISVs on ...
(Date:7/14/2014)... Crystal Dental has recently announced that ... has been made via LAD Solutions in in order to ... been made in order to draw in new patients that ... , Crystal Dental offers a variety of services for both ... Crystal Dental include cosmetic dentistry procedures such as porcelain veneers ...
(Date:7/13/2014)... July 14, 2014 Save the Date for ... Hospital in Jacksonville, FL , BOXWOODS & BowTies “A Modern ... , Who: The Women’s Board of Wolfson Children’s Hospital ... Show to continue their ongoing commitment to raising funds ... children. , What: The 2014 Art & Antiques Show ...
Breaking Medicine News(10 mins):Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 2Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 3Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 2Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 3Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 2Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 3Health News:Crystal Dental Announces the Opening of New Office Location in Sacramento 2Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 2Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 3Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 4Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 5Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 6Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 7Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 8Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 9
... of Pennsylvania School of Veterinary Medicine have demonstrated ... attacks the cellular machinery, disrupts normal cellular function ... identified for the first time that mitochondria, the ... cellular fuel, are the target of tetrachlorodibenzodioxin, or ...
... insurance status are associated with survival rates among patients ... the December issue of Archives of OtolaryngologyHead & Neck ... U.S. men and women each year are diagnosed with ... background information in the article. For many years, total ...
... the industry,s technology leader in end-to-end bill cycle ... ... Workers, Compensation Payers, CONCORD, Calif., Dec. ... in providing catastrophic and complex,medical management services has entered ...
... DETROIT, Dec. 17 With much of the state experiencing,one ... more on,the horizon, Blue Cross Blue Shield of Michigan and ... mind and go slow,when clearing snow from driveways and sidewalks ... * Shoveling snow ...
... and Lab Accreditation ... ... Quality and Compliance Management Software, announced today that,it has donated over ... whose mission is to improve lives,worldwide through research, education, and services ...
... offers a critical appraisal of published research exploring the benefits of patients adhering to each of ... healthy eating habits , ... glucose monitoring , medication compliance ... healthful coping , ...
Cached Medicine News:Health News:Agent orange chemical, dioxin, attacks the mitochondria to cause cancer, says Penn research team 2Health News:Study examines factors associated with survival in advanced laryngeal cancer 2Health News:Paradigm Selects Jopari to Provide E-Billing Gateway for Customers 2Health News:Paradigm Selects Jopari to Provide E-Billing Gateway for Customers 3Health News:Blue Cross Blue Shield of Michigan Says Don't Let Snow Be a Pain: Ease into Clearing Sidewalks, Drives 2Health News:Blue Cross Blue Shield of Michigan Says Don't Let Snow Be a Pain: Ease into Clearing Sidewalks, Drives 3Health News:IQS Donates Quality Management Software to Family Health International 2Health News:IQS Donates Quality Management Software to Family Health International 3
(Date:7/10/2014)... JORDAN, Utah , July 10, 2014  BC ... solutions, and MiE America , Inc., a leading ... have entered into a long-term agreement naming BC Technical ... the US. MiE and BC Technical ... strategic agreement to establish BC Technical as the service ...
(Date:7/10/2014)... July 10, 2014 CVS Caremark Corporation (NYSE: ... has approved a quarterly dividend of $0.275 (27.5 cents) per ... on August 1, 2014, to holders of record on July ... CVS Caremark is dedicated to helping people on their path ... the United States . Through the company,s ...
(Date:1/15/2014)... DUBLIN , Jan. 15, 2014  Research and Markets ... "Dental Consumables Market - Global Industry Analysis, Size, ... report to their offering. (Logo: ... products which are used on patients in order to ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3
... LITTLE FALLS, N.J., March 3, 2011 Cantel Medical Corp. ... its second quarter ended January 31, 2011 on Wednesday, March ... to discuss the results at 11:00 AM ET. Participating in ... Krakauer, President and CEO; Seth R. Segel, Executive Vice President; ...
... ConvaTec Healthcare, a world-leading developer, manufacturer and marketer of ... announced that, recognizing favorable conditions in the credit markets, ... a portion of its senior secured term loans originally ... While the year-end audit process is ongoing, ConvaTec presently ...
Cached Medicine Technology:Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Second Quarter Ended January 31, 2011 2ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans 2ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans 3
... Borrelia (Lyme) test is an ... for the qualitative detection of ... and related Borrelia burgdorferi antibodies ... detected in serum as an ...
... Tests are qualitative enzyme immunoassays (EIA) for ... (IgG or IgM, respectively) in serum. Equivocal ... be supplemented with a standardized western blot ... to support a clinical diagnosis of B. ...
... dot-blot assay system combining microwell EIA and ... antigen set at a clinically meaningful cutoff ... detected using the same reagent system used ... antigens detected in Auto 4 detecting the ...
... The ImmunoWELL Cardiolipin Antibody (IgM) ... (EIA) for the quantitative detection ... in serum and is used ... the risk of thrombosis in ...
Medicine Products: